Lymphoma
By Julia Cipriano, MS / November 25, 2024 / 2024 NCCN Annual Congress: Hematologic Malignancies
“While clinical trials emphasize improvement in cure rates for patients with advanced classical Hodgkin lymphoma, an important goal is reducing the potential long-term effects of treatment,” commente...